Clinical trial Recruiting at 2 sites Interventional Ages 50 and up

Using internet therapy to reduce depression and cognitive decline in older ICU survivors

Official title: Attenuating DEPression With Internet CBT to Slow Cognitive Decline in Older ICU Survivors(ADEPT-ICU)

Run by Indiana University · NCT06627894 · Data updated 2026-11-12

This study is testing if an online therapy program can help older adults who have been in the ICU feel less depressed and think better.

Quick facts

Study typeInterventional
Ages50 Years and up
SexAll
Enrollment300 (estimated)
SponsorIndiana University
Academic / other
Locations2 sites (Indianapolis, Indiana and 1 other locations)
StatusRecruiting
StartedMarch 13, 2025
Main results expectedOctober 30, 2029
Study endsOctober 30, 2029
Registry record updatedDecember 17, 2025
Trial IDNCT06627894 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are older adults aged 50 and above who have been admitted to the ICU for more than 48 hours and are experiencing moderate to severe depressive symptoms.

Probably not a fit

Patients with a diagnosis of dementia, severe mental illness, or those with a life expectancy of less than one year may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial evaluates the effectiveness of an internet-based cognitive behavioral therapy (CBT) intervention called Good Days Ahead (GDA) aimed at reducing depression and subjective cognitive decline in older adults who have survived an intensive care unit (ICU) stay. The study involves a two-arm randomized controlled trial comparing the internet CBT intervention to an active control group. Participants will be older adults aged 50 and above who have experienced moderate to severe depressive symptoms after ICU hospitalization. The goal is to determine if addressing depression can help slow cognitive decline and reduce the risk of Alzheimer's disease and related dementias.

Why it matters

Potential benefit: If successful, this intervention could significantly improve mental health and cognitive outcomes for older ICU survivors, potentially lowering the risk of developing Alzheimer's disease and related dementias.

How similar studies have gone: While there have been studies on CBT for depression, this specific approach targeting cognitive decline in older ICU survivors is novel and has not been rigorously tested on a large scale.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria

1. 50 years of age and older
2. Admitted to the intensive care for greater \> 48 hours
3. Able to understand and provide informed consent
4. Elevated depressive symptoms, defined as Screening PHQ-9 or PHQ-8 ≥ 10 or Screening PHQ-9 or PHQ-8 = 5-9 with the presence a core symptom of anhedonia (PHQ-9 or PHQ-8 Item 1) or depressed mood (PHQ-9 or PHQ-8 Item 2)
5. Willing to participate in cognitive testing
6. Access to a telephone
7. Discharge to home or an independent or assisted living facility
8. Response is a 1,2, or 3 on PHQ-9 or PHQ-8 item 7, answered yes to "Have you experienced a change in your memory or other aspect of thinking in the past 1 to 3 years?", or score in the 25% percentile or lower on the Montreal Cognitive Assessment (MOCA) based on normative data which account for age, gender, race, ethnicity and education.

Exclusion Criteria:

1. Diagnosis of dementia or neurodegenerative disease (e.g. Alzheimer's disease, vascular dementia as per EHR and IQCODE, or Parkinson's disease) or on anti-dementia medications prior to ICU stay
2. Diagnosis of severe mental illness (bipolar disorder, schizophrenia, schizoaffective) as per EHR and screening questions
3. Persistent psychotic symptoms after ICU stay which would interfere with successful completion of intervention
4. Recent or recurrent alcohol or substance use disorder as per HER and Drug Abuse Screening Test
5. Life expectancy less than 1 year (e.g. terminal cancer diagnosis, discharged on hospice)
6. Ischemic or hemorrhagic stroke, traumatic brain injury, or undergoing neurosurgery prior, during or after ICU stay
7. Uncorrected visual or auditory impairment including legal blindness or deaf
8. Status post tracheostomy and not able to communicate
9. Incarcerated or on parole after ICU stay

Where it's running

  • Eskenazi Hospital
    Indianapolis, Indiana, United States
    Recruiting
  • IU Health Methodist Hospital
    Indianapolis, Indiana, United States
    Recruiting

Study contacts

  • Principal investigator: Babar Khan, MD, MS — Indiana University
  • Study coordinator: Babar Khan, MD, MS
  • Email: bakhan@iu.edu
  • Phone: 317-274-9132

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.